Logo image
Decoding dangerous death: how cytotoxic chemotherapy invokes inflammation, immunity or nothing at all
Journal article   Peer reviewed

Decoding dangerous death: how cytotoxic chemotherapy invokes inflammation, immunity or nothing at all

R.G. van der Most, A.J. Currie, B.W.S Robinson and R.A. Lake
Cell Death and Differentiation, Vol.15(1), pp.13-20
2008
url
Link to Published Version *Subscription may be requiredView

Abstract

Chemotherapy and immunotherapy can be either synergistic or antagonistic modalities in the treatment of cancer. Cytotoxic chemotherapy not only affects the tumor but also targets dividing lymphocytes, the very cells that are required to develop an immune response. For this reason, chemo- and immunotherapy have been seen as antagonistic. However, cell death can be immunogenic and the way in which chemotherapeutic drug kills a tumor cell is likely to be an important determinant of how that dying cell interacts with the immune system and whether the interaction will lead to an immune response. When a cell dies as the result of infection, the immune system responds rapidly and the system of Toll-like receptors (TLR) plays a key role in this process. In this review, we will briefly summarize the intracellular signaling pathways that link TLR ligation with immune activation and we will address the questions where and how TLRs recognize their targets.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.6 Immunology
1.6.214 Checkpoint Inhibition
Web Of Science research areas
Biochemistry & Molecular Biology
Cell Biology
ESI research areas
Molecular Biology & Genetics
Logo image